Karnofsky Performance Status and ECOG performance status alone leaves a lot to be desired for the practicing oncologist.
Katie Kerrigan, DO
Advertisement
Articles by Katie Kerrigan, DO
Advertisement
Latest Updated Articles
Incorporating PROs Can Improve Patient Care and Outcomes in OncologyPublished: November 30th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
4
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
5